MedTrace Logo

Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care

NCT02752061 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 979

Last updated 2020-07-23

No results posted yet for this study

Summary

Diagnostic and treatment delays contribute substantially to disparities in cancer morbidity and mortality between low- and middle- income countries (LMICs) and high-income countries. Individuals present with advanced stage disease resulting in minimal chance for cure or long-term survival.

The Potlako project will implement and evaluate a multifaceted intervention to test the hypothesis that a package of enhanced coordination of care including an electronic messaging, transportation support, and training targeted at generalist clinicians at primary and secondary level facilities, can reduce time to diagnosis and stage at diagnosis for HIV-infected individuals with cancer.

Conditions

  • Neoplasms
  • HIV
  • Healthcare Disparity

Interventions

OTHER

Potlako intervention

Multicomponent intervention including: * provider training on early detection and diagnostic approaches to cancer * patient education on importance of obtaining timely cancer diagnosis * provision of a patient navigator to facilitate diagnosis and entry into care * provision of transportation support to vulnerable patients

Sponsors & Collaborators

  • Brigham and Women's Hospital

    collaborator OTHER

  • Botswana Harvard AIDS Institute Partnership

    collaborator OTHER

  • Botswana Ministry of Health

    collaborator OTHER_GOV

  • Dana-Farber Cancer Institute

    collaborator OTHER

  • Harvard School of Public Health (HSPH)

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-13
Primary Completion
2020-07-21
Completion
2020-07-21

Countries

  • Botswana

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02752061 on ClinicalTrials.gov